SCHEDULE 13G: Beryl Capital Entities Disclose Significant Stake in Streamline Health Solutions

Beryl Capital Management LLC, along with affiliated entities and control person David A. Witkin, has disclosed beneficial ownership of 8.6% of Streamline Health Solutions Inc.'s common stock.

Summary

• Beryl Capital Management LLC, Beryl Capital Management LP, and David A. Witkin each reported beneficial ownership of 374,030 shares of Streamline Health Solutions Inc. common stock, representing 8.6% of the class.
• Beryl Capital Partners II LP, an affiliate, reported beneficial ownership of 301,389 shares, representing 7.0% of the class.
• The percentages are calculated based on 4,331,315 shares of Common Stock outstanding as of April 28, 2025, as disclosed in the Issuer's Form 10-K/A.
• All reported shares are held with shared voting and shared dispositive power; no sole voting or dispositive power was reported by any of the filing persons.
• Beryl Capital Management LLC acts as the investment adviser to Beryl Capital Partners II LP and other accounts, and is the general partner of Beryl Capital Management LP, which in turn is the general partner of Beryl Capital Partners II LP.
• David A. Witkin is identified as the control person of Beryl Capital Management LLC.
• The filing is a Schedule 13G, indicating that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The document is a standard Schedule 13G filing, which is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the issuer's performance or prospects. It is a neutral informational filing.

Future Outlook

NA

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing indicates a significant passive investment by Beryl Capital Management in Streamline Health Solutions, a company operating in the healthcare technology sector. Such disclosures are common for institutional investors taking substantial, non-controlling positions in publicly traded companies.

Stakeholder Impact

• Shareholders: The disclosure of a new significant institutional holder (Beryl Capital Management) may be viewed positively by some investors as it signals institutional interest and potential confidence in the company, while others may monitor for any future changes in ownership or intent.

Key Dates

Keywords

Streamline Health Solutions Inc., Beryl Capital Management LLC, Beneficial Ownership, Schedule 13G, Common Stock, Investment Adviser, Institutional Investor, Healthcare Technology